Todays Report: The Envision Healthcare Holdings Inc. (EVHC) Scheduled to Post Quarterly Earnings on Thursday

The Envision Healthcare Holdings Inc. (EVHC) Scheduled to Post Quarterly Earnings on Thursday

Envision Healthcare Holdings Inc. (NYSE:EVHC) is scheduled to post its quarterly earnings results after the market closes on Thursday, October 20th. Analysts expect Envision Healthcare Holdings to post earnings of $0.37 per share for the quarter. Envision Healthcare Holdings has set its FY16 guidance at $1.42-1.47 EPS.

Envision Healthcare Holdings (NYSE:EVHC) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported $0.34 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by $0.02. The firm earned $1.64 billion during the quarter, compared to the consensus estimate of $1.66 billion. Envision Healthcare Holdings had a net margin of 1.88% and a return on equity of 11.74%. The business’s revenue for the quarter was up 21.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 earnings per share. On average, analysts expect Envision Healthcare Holdings to post $1.43 EPS for the current fiscal year and $1.67 EPS for the next fiscal year.

Shares of Envision Healthcare Holdings Inc. (NYSE:EVHC) opened at 21.24 on Tuesday. Envision Healthcare Holdings Inc. has a one year low of $18.31 and a one year high of $38.64. The stock has a 50 day moving average price of $21.83 and a 200-day moving average price of $23.25. The company has a market capitalization of $3.98 billion, a price-to-earnings ratio of 35.40 and a beta of 0.42.

A number of research analysts have recently commented on EVHC shares. Citigroup Inc. upgraded Envision Healthcare Holdings from a “neutral” rating to a “buy” rating and dropped their price target for the company from $27.00 to $26.00 in a research note on Monday, September 26th. Zacks Investment Research upgraded Envision Healthcare Holdings from a “sell” rating to a “hold” rating in a research note on Thursday, September 29th. Canaccord Genuity reiterated a “buy” rating and issued a $32.00 price target on shares of Envision Healthcare Holdings in a research note on Friday, August 5th. Cantor Fitzgerald reiterated a “buy” rating and issued a $31.00 price target on shares of Envision Healthcare Holdings in a research note on Thursday, September 8th. Finally, Mizuho increased their price target on Envision Healthcare Holdings from $24.00 to $27.00 and gave the company a “neutral” rating in a research note on Friday, June 24th. Seven equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $30.85.

Several institutional investors have recently added to or reduced their stakes in the company. Pacer Advisors Inc. boosted its position in Envision Healthcare Holdings by 507.5% in the second quarter. Pacer Advisors Inc. now owns 6,561 shares of the company’s stock worth $166,000 after buying an additional 5,481 shares during the period. Zacks Investment Management bought a new position in Envision Healthcare Holdings during the second quarter worth about $212,000. Skandinaviska Enskilda Banken AB publ bought a new position in Envision Healthcare Holdings during the second quarter worth about $226,000. Levin Capital Strategies L.P. bought a new position in Envision Healthcare Holdings during the second quarter worth about $228,000. Finally, Point72 Asia Hong Kong Ltd bought a new position in Envision Healthcare Holdings during the second quarter worth about $229,000.

Envision Healthcare Holdings Company Profile

Related posts

Leave a Comment